Home
overview

The SMi Group is pleased to invite you to the inaugural
Aseptic Processing Conference
NEW DATE 20th - 21st September, 2021 | London, United Kingdom
-----------------------------------------------------------------------
The aseptic processing industry has seen many changes during its progression towards the 21st century. With advances in innovative therapeutic manufacturing such as ATMPs, pragmatic barrier system applications, adaptability and modularity in fill finish, robotics and automation, small and agile product manufacturing, just to name a few. In 2018, the global aseptic processing market was valued over $56 trillion and is estimated to increase in net revenue upwards $124 trillion by 2027, with a CAGR growth of 9.18%.

The industry is ever changing and with the advent of innovative therapeutics taking hold, regulators and industry leaders are prompted to take proactive approaches to get treatments to patients faster. Join us this year to explore novel and developing technologies that tackle the most pressing challenges and push innovation in the world of aseptic processing and sterile manufacturing.
 

  • LISTEN to the latest regulatory updates in the aseptic processing industry from leading regulatory bodies
  • DISCUSS case studies from leading pharmaceutical companies revolutionizing the industry
  • EXPLORE advances in ATMP facility design and contamination control from emerging and established pharmaceutical and biopharmaceutical companies
  • DISCOVER the future of contamination control through a look at the advent of automated systems, continuous manufacturing and monitoring and reduced intervention from leaders in industry

Conference programme

8:00 Registration & Coffee

9:00 Chairman's Opening Remarks

James Drinkwater

James Drinkwater, Chairman of PHSS and Head of GMP Compliance F Ziel GmbH, PHSS: Pharmaceutical & Healthcare Sciences Society
View Bio

9:10 Discuss the revisions and the impact of Annex 1 on aseptic manufacturing

Di Morris

Di Morris, Senior Manager, Team Leader, GSK
View Bio

• Navigating through the latest revisions of Annex 1and its impact on aseptic manufacturing
• An account of the current state of the Annex 1 and a comparison with parallel guidance documents
• Discuss the ley requirements such as QRM, process simulations, container closure integrity, isolators and barrier systems, and much more
• Looking into the impact of Annex 1 with respect to current control and monitoring strategies
• How the upcoming changes will affect pharmaceutical companies globally

9:50 FDA’s current expectations on sterile biotechnology drug product manufacturing

Scott Nichols

Scott Nichols, Microbiologist, FDA
View Bio

• FDA’s regulatory framework relating to Aseptic Processing
• Discussion of common review/filing issues relating to sterility assurance
• Outcomes from GMP inspections
 

10:30 Morning Coffee

11:00 Contamination control strategies (CCS) applied to three different product types for Annex 1 compliance

James Drinkwater

James Drinkwater, Chairman of PHSS and Head of GMP Compliance F Ziel GmbH, PHSS: Pharmaceutical & Healthcare Sciences Society
View Bio

• CCS for Aseptic processing: Formulation and Filling an ATMP viral vector
• CCS for Aseptic process filling of Cytotoxic products including lyophilization process
• CCS for Aseptic filling of bulk vaccines into vials
 

11:40 Use of quality risk management for effective deviation investigations in aseptic environment

Kevin Jenkins

Kevin Jenkins, Consultant, Quality Excellence Consulting LLC
View Bio

• Conducting the investigation using DMAIC Six Sigma approach
• Use of Failure Mode Analysis (FEMA) tools
• Understanding common cause vs special cause deviations and how to respond for results
• Use of Quality Risk Management
             o Escalation as required (FAR/compliance reporting requirements
             o Review of safety/medical implications to patients
             o Holistic approach
• Choosing effective CAPA
• Control phase and demonstrated CAPA effectiveness
• Case studies, investigations and corrective actions for:
             o Media fill failure
             o Sterility failure
             o Microbiological contamination from personnel/environment
 

12:20 Networking Lunch

13:20 Strategies in developing an isolator/RABS glove management strategy for aseptic processing

Stephen Yang

Stephen Yang, Director - Sterile Validation COE, MSD
View Bio

• Global regulatory updates
• Review key characteristic risks between isolators and RABS – risk mitigation strategies such as impact investigations, response to leak detection and leak integrity monitoring
• Reviewing guideline documentation for glove management and QRM for gloves
• Case study of isolator glove management control strategy
 

14:00 Implementation of a global contamination control program – A field report

Christoph Hansy

Christoph Hansy, Associate Director, Takeda
View Bio

• Overview: From the idea to the roll out of a global contamination control program (CCP)
• Contamination control program key elements and documents
• Current status / sustain phase of the contamination control program
 

14:40 Afternoon Tea

15:10 Risk Based Approach to Cleaning and Disinfection is sterile manufacturing facilities

Aaron Mertens

Aaron Mertens, Technical Service Specialist, Steris Corporation

• Covers risk assessment and CAPA investigations on fungal spore and bacterial spore contamination in cleanrooms
• Discuss the most current regulations regarding conducting CAPA investigations
• Examples of current excursion investigations highlighting preventive measures will be presented as case studies
• Detailed coverage of the latest methods in conducting risk-based investigations and risk maps
• Learn methods to proactively prevent contamination events from occurring through discussing the most common sources of bioburden contamination
 

15:50 Compliance and Quality assessment to support QP certification

Ulrich Kissel

Ulrich Kissel, Founder, CEO and Consultant, KisselPharmaConsulting GmbH
View Bio

• Compliance assessment of an aseptic product - what matters
• Quality assessment of an aseptic product - what matters
• Are there significant differences between aseptic products and ATMP products?
• Learn from case studies
 

16:30 Chairman’s Closing Remarks and Close of Day One

James Drinkwater

James Drinkwater, Chairman of PHSS and Head of GMP Compliance F Ziel GmbH, PHSS: Pharmaceutical & Healthcare Sciences Society
View Bio

8:30 Registration & Coffee

9:00 Chairman's Opening Remarks

Richard Denk

Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
View Bio

9:10 Challenges in designing a new VHP decontaminated aseptic filling line

Serena Ambrosini

Serena Ambrosini, Sterile Manufacturing Manager, AstraZeneca
View Bio

• Risk based approach to define VHP decontamination zoning and frequency
• Evaluation of VHP impact on product and materials
• Optimization of line design to fulfil the desired high-throughput and to meet draft Annex 1
 

9:50 Aseptic Competence at Fresenius Kabi – Case studies of Fresenius Kabi´s global aseptic manufacturing

Benedikt Reichart

Benedikt Reichart, Global Business Development Manager, Fresenius Kabi Austria GmbH

• Aseptic competence at Fresenius Kabi for a broad variety of containers
• Case studies
          o Graz, Austria
          o Melrose Park, US
          o Wilson, US
 

10:30 Morning Coffee

11:00 Cleanroom DeepTraining – possibilities and frontiers of Virtual Reality

11:40 A modular and flexible filling platform for toxic and biologically hazardous products that may include a freeze-drying process step

• Introduction to EirGen and the Toxic product filling line project in Ireland – Waterford.
• Aseptic-Containment process design for filling toxic and biologically hazardous products.
• Learning from project execution together with partners.
• QRM and challenges in adaption of generic GMP
• Operational flexibility and project success factors
 

Dermot O'Riordan

Dermot O'Riordan, Business Development Manager, EirGen Pharma Ltd

James Drinkwater

James Drinkwater, Chairman of PHSS and Head of GMP Compliance F Ziel GmbH, PHSS: Pharmaceutical & Healthcare Sciences Society
View Bio

12:20 Networking Lunch

13:20 Fulfilling GMP compliance in aseptic processing and ATMP manufacturing

Richard Denk

Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
View Bio

• Regulatory updates Annex 1 Draft and PICs Annex 2B draft
• Key Requirements for Processing in Isolator Technologies like Glove Management and Surface Decontamination
• Novel concepts in fill-finish
• Managing cross contamination in multi-product facilities
 

14:00 Designing a quality management system (QMS) for ATMP manufacturing

Jingjing Li

Jingjing Li, Senior Manager, QA, Orchard Therapeutics
View Bio

• Reviewing the elements of a QMS for ATMP manufacturing
• Integrating contamination control into the QMS
• Aligning QMS with operational models
• Managing QMS lifecycle
 

14:40 Afternoon Tea

15:10 AAV Manufacture and Drug Delivery - Gene Therapy Moving from Small to Large Patient Populations

Ian Pitfield

Ian Pitfield, VP CMC, Gyroscope Therapeutics
View Bio

• AAV gene therapy process development
• Analytical development and product characterisation
• Technology transfer and GMP manufacture
• Formulation, supply chain and drug delivery
 

15:50 Exploring a case study on an integrated aseptic processing platform: Utility of a viral vector in CAR-T cell therapy

Wayne Askew

Wayne Askew, Aseptic Filling Team Leader, Oxford Biomedica Ltd

• Challenges in meeting QRM principles when modifying general GMP
• A tour through Oxford BioMedica’s OXBOX facility achieving integrated formulation and filling platforms suitable for expanding processing demands of different ATMP indicators
• Key role of aseptic containment in managing cross contamination
• A look at the case study in detail: Collaboration between Oxford BioMedica and Novartis
 

16:30 Chairman’s Closing Remarks and Close of Day Two

Richard Denk

Richard Denk, Senior Consultant Aseptic Processing & Containment, SKAN AG
View Bio

+

FEATURED SPEAKERS

Di Morris

Di Morris

Senior Manager, Team Leader, GSK
James Drinkwater

James Drinkwater

Chairman of PHSS and Head of GMP Compliance F Ziel GmbH, PHSS: Pharmaceutical & Healthcare Sciences Society
James Polarine Jr

James Polarine Jr

Senior Global Technical Service Manager, Steris Corporation

Aaron Mertens

Technical Service Specialist, Steris Corporation
Aaron Mertens

Benedikt Reichart

Global Business Development Manager, Fresenius Kabi Austria GmbH
Benedikt Reichart

Christoph Hansy

Associate Director, Takeda
Christoph Hansy

Christoph Hansy has more than 13 years of experience in the pharmaceutical industry. He is currently member of the Global Microbiology Management Team at Takeda and based in Vienna, Austria.
In his current role he provides subject matter expertise as well as technical leadership on microbiological matters, such as method related projects, microbial control strategies, and contamination/investigation support in a global role. During his career he has undergone several company integration programs and was therefore able to gather multiple insights in different contamination/microbiological control strategies.
Since 2017 he is involved in the development, implementation and sustain phases of a global contamination control program.

 

Dermot O'Riordan

Business Development Manager, EirGen Pharma Ltd
Dermot O'Riordan

Di Morris

Senior Manager, Team Leader, GSK
Di Morris

Di Morris - MRSC Chemistry and PGDiPS and a Qualified Person under permanent provisions since 1993; Pharmaceutical industry for over 30 years/ a number of years as a Medicines Inspector for the MHRA. Di/worked in the areas of Quality Control (Chemistry and Microbiology), Quality Assurance and Regulatory Affairs/worked with a wide range of dosage forms including sterile products, biological, and non-sterile products.

Ian Pitfield

VP CMC, Gyroscope Therapeutics
Ian Pitfield

Ian graduated from the University of Cambridge in 1992 with a PhD in Biotechnology. After a short period working for SAF developing downstream processes for high value, low volume products, Ian moved to SmithKline Beecham/GlaxoSmithKline to start a 17-year Analytical Scientist/Management career in Pharmaceutical Drug development. From June 2012, Ian transitioned to CMC Project Leadership in GSK’s Cell and Gene Therapy team leading CMC development, validation and regulatory submission of Strimvelis, the world’s first approved ex-vivo autologous gene therapy. Ian started as VP, CMC at Gyroscope Therapeutics in January 2017.

James Drinkwater

Chairman of PHSS and Head of GMP Compliance F Ziel GmbH, PHSS: Pharmaceutical & Healthcare Sciences Society
James Drinkwater

Together with the role at F Ziel James is the elected Head of the Not-for-Profit PHSS: Pharmaceutical & Healthcare Sciences Society Aseptic processing and Containment special interest groups. James is a Pharmaceutical process engineer with additional education in Pharmaceutical microbiology. Working experience includes 10 years in radio pharmaceutical manufacturing and over 20 years working in sterile product manufacturing support where increasingly aseptic processing applies. James is a Subject matter expert in Barrier Technology (Isolators and RABS) and Bio-decontamination with Hydrogen peroxide vapour (H202-VHP). James is also a Member of ISPE and Pharmaceutical Quality Group UK (PQG).

James Polarine Jr

Senior Global Technical Service Manager, Steris Corporation
James Polarine Jr

Mr. Polarine is a senior technical service manager at STERIS Corporation. He has been with STERIS Corporation for twenty years. His current technical focus is microbial control in cleanrooms and other critical environments. Mr. Polarine is a 2019 PDA Michael S. Korczynski Award recipient. He has lectured in North America, Europe, Middle East, Asia, and Latin America on issues related to cleaning and disinfection, microbial control in cleanrooms and validation of disinfectants. Mr. Polarine is a frequent industry speaker and published several PDA book chapters and articles related to cleaning and disinfection and contamination control. He is active as co-chair on the PDA’s microbial investigations task force. He was a co-author on PDA’s Technical Report #70 on Cleaning and Disinfection. Mr. Polarine teaches industry regulators as well as the pharmaceutical, biotech, and medical device industries at the PDA and the University of Tennessee. Mr. Polarine currently teaches the cleaning and disinfection course as part of the PDA Aseptic Processing Course and at the University of Tennessee Parenteral Medications Course. Mr. Polarine is current President for the PDA Missouri Valley Chapter and Technical Coordinator for the IEST. Mr. Polarine graduated from the University of Illinois with a Master of Arts in Biology. He previously worked as a clinical research coordinator with the Department of Veterans Affairs in St. Louis, MO and as a biology and microbiology instructor at the University of Illinois. His main hobby is storm chasing and is very active in tornado research and tornado safety.

Jingjing Li

Senior Manager, QA, Orchard Therapeutics
Jingjing Li

Jing’s professional experience spans across Europe, Asia and North America, in industries including ATMP, bio-pharma and medical devices. Her focus for the most recent five years has been ATMP operations and quality assurance. At Lonza Singapore, she managed the cell therapy operations team with manufacturing activities seven days a week. At the Cell and Gene Therapy Catapult Stevenage Manufacturing Centre, she led the QA team and worked cross-functionally to build a fit-for-purpose quality management system, which resulted in successful facility GMP licensure. Currently Jing is with Orchard Therapeutics providing QA guidance to the CMC Technical Operations team across various programmes.

Kevin Jenkins

Consultant, Quality Excellence Consulting LLC
Kevin Jenkins

Kevin joined Pfizer through the Upjohn Company in 1983 as a Research Chemist in Kalamazoo, MI. He held positions of increasing responsibility in aseptic operations and, in 1996, was named Laboratory Supervisor. In 1998, Kevin accepted an international assignment as the Corporate Compliance Professional in Halden, Norway, where he prepared the IV bag facility for the first FDA Pre-Approval Inspection.

Kevin returned to Kalamazoo in 1999 as the Director Validation/Compliance. In 2003, he moved to Terre Haute, IN, and was appointed Director Quality Operations. Kevin transitioned into a technical services position in 2007, leading product development for aseptic and inhalation products. Kevin moved to Lincoln, NE in 2008, and was appointed Director, leading the site Lean Manufacturing, Continuous Improvement and Six Sigma programs. In 2009, he was appointed Director, Quality Operations, responsible for Vaccine/Biologics Animal Health Quality. Kevin returned to Kalamazoo in 2010, as Director, Quality Operations for the site. Between 2012 - 2018, he held senior quality leadership positions: Vice President, Global Quality; VP, Global Aseptic Quality; and VP Quality Excellence. In 2018, Kevin was appointed VP Sterile Injectables Quality with responsibility for twelve plants worldwide.

Kevin retired from Pfizer October 2019 after 36 years. He is currently a consultant with Quality Excellence Consulting LLC.

 

Richard Denk

Senior Consultant Aseptic Processing & Containment, SKAN AG
Richard Denk

Richard Denk is working at the company SKAN AG, headquartered in Allschwil in the position Senior Consultant Aseptic Processing & Containment. Mr. Denk founded 10 years ago the expert Containment group of the ISPE D / A / CH. The Containment Group published the ISPE Containment Manual Mr. Denk was responsible for in September 2015. He is Member of the ISPE SIG BioTech Group in Europe and Steering Committee Member of the ISPE SPP (Sterile Product Processing) CoP. Furthermore Mr. Denk founded the PDA Expert Group about Cleaning and Cross Contamination Requirements for Biopharmaceutical Products and published this topic as PDA Paper and task team member of the PDA Expert Group for Isolators. Mr. Denk is co Autor of the ISPE OSD Baseline Guide Volume 2 and Volume 3. Mr. Denk has spent 20 years with the subject production of highly active / highly hazardous substances and has developed the containment pyramid.

Scott Nichols

Microbiologist, FDA
Scott Nichols

Scott Nichols graduated from the University of Iowa with an Honours BS in Biochemistry and continued as a Fulbright Scholar at the Pasteur Institute. His Ph.D. was earned in Molecular Biophysics at Johns Hopkins University. He currently works as a Quality Assessment Lead in the Division of Biotechnology Manufacturing at the FDA. He has expertise in the microbial control/sterility assurance review of biotechnology drug substance/drug product applications and leads inspections of the associated manufacturing facilities. He is an author of PDA’s Technical Report No. 82 on Low Endotoxin Recovery and works on microbial control strategies for emerging technologies.

Serena Ambrosini

Sterile Manufacturing Manager, AstraZeneca
Serena Ambrosini

Serena Ambrosini has a MSc in Pharmaceutical Chemistry (2007) and a PhD in Analytical Chemistry (2010). After her academic studies she has specialized in aseptic manufacturing, heat sterilization and VHP decontamination. Serena has worked in Fedegari and GSK in Italy and she currently holds the position of Sterile manufacturing Manager in AstraZeneca (UK). She is accountable for and lead improvement projects to deliver enhanced sterility assurance and to develop a robust sterility assurance business process and strategy (e.g. optimisation of the cleanroom processes and steriliser validation, implementation of VHP in cRABS and transfer hatch).

Stephen Yang

Director - Sterile Validation COE, MSD
Stephen Yang

Stephen Yang earned his Ph.D. degree in Bioengineering from the Georgia Institute of Technology, Atlanta, GA, USA. He has had over ten years’ experience in technical / validation support to manufacturing of vaccines, biologics, and pharmaceuticals products. Stephen is currently a Director in the Global Sterile / Validation Center of Excellence at Merck & Co. and is an expert in aseptic processing and pharmaceutical manufacturing microbial control.

Ulrich Kissel

Founder, CEO and Consultant, KisselPharmaConsulting GmbH
Ulrich Kissel

With more than 25 years experience in the Pharma industry Ulrich Kissel is today running his own consultancy company with focus on GMP systems. Before he was more than 20 years in Roche (Switzerland, Germany) holding various managerial positions in Quality and Supply Chain Management including 10 years in the role of a Qualified Person for marketed and clinical products with focus on biotechnology. He serves as chairman to the European QP Association with more than 3000 members within all EU member states and beyond. Ulrich is pharmacist with an Ph.D. in biochemistry.

Sponsors

Exhibitors

Official Media Partner

Supporters

Workshops

VENUE

Copthorne Tara Hotel

Scarsdale Place, Kensington, London, United Kingdom

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

A number of our clients have been approached by third party organisations offering to book hotel rooms. We would advise that you do not book through them as they are not representing the SMi Group. SMi Group books all hotel rooms directly. If you are approached by a third party organisation then please contact us before making any bookings. If you have already booked a hotel room using a third party organisation, we would highly recommend contacting the hotel you were booked into to ensure a booking has been made for you. We would also advise you to please check the terms and conditions of the booking carefully.
HOTEL BOOKING FORM

Past Attendees

Download

Workshop Programme

Download

Event Programme

Download

Aseptic Processing Conference Chairs & Speakers

Download

Brochure

Download

Sponsors


Innerspace

Sponsors
https://www.innerspace.eu/

Innerspace develops revolutionary training systems, in which aseptic production employees learn to master the key moments of their work. Innerspace uses high end Virtual Reality technology to implement research breakthroughs in Human Error Analysis and Transfer research into a powerful DeepTraining system. The DeepTrainings modules offer safe environments for repeatable, focused virtual experiences that create real, goal driven work experience. In addition, the Training Management System supports documentation and integration of training data. All that allows Innerspace to support its customers with a cutting-edge digital solution to train employees in one of the most critical fields of human interaction in aseptic manufacturing.

Exhibitors


STERIS

Exhibitors
http://www.sterislifesciences.com

STERIS Life Sciences is your trusted partner in contamination control. For over 100 years, STERIS has been a global leader and expert in the industries of sterilization, cleaning and infection control.

Today, we continue to build on this heritage by providing the products and resources you need throughout every step of your process. From innovation to results, our comprehensive portfolio of products and services is designed to meet your needs.

With offices located worldwide and technicians in over 100 countries, you can count on us to be where you are when you need us, every step of the way. Trust STERIS Life Sciences to help you create a healthier and safer world.


Media Partners


Rapid Microbiology.com

Official Media Partner
https://www.rapidmicrobiology.com

rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions. To keep up-to-date with the latest microbiology news get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.


Pharma Journalist

Official Media Partner
http://www.pharmajournalist.com

Pharma Journalist is a product of Kellen Media. Pharma Journalist is one of the leading website covering the need of global Pharmaceutical Industry. Articles like latest news, trends, analysis, market report, press releases, whitepapers, case studies, etc. published on pharmajournalist.com helps Industry professionals and decision makers to stay on the top of this fast-paced industry. Pharma Journalist aims of providing fast and informative articles to its readers and subscribers.


Farmavita

Official Media Partner
https://farmavitar.com

FarmavitaR+ is the professional network of experts and service providers. Network is gathering local consultants from 90 countries in Europe, Asia, North America, Latin America, Australia and Africa. Management of international, multi-centre projects is our core competence. FarmavitaR+ is providing solutions related to pharmaceutical, medical device, food supplement and cosmetic products. Scope of services is related to solutions for product development, quality assurance, clinical trials, product registration, portfolio analysis, lifecycle management, vigilance/risk management, pricing/reimbursing, market access and promotional compliance. FarmavitaR+ is brand name of Farmavita Regulanet Ltd. Visit https://farmavitar.com for more information. Outsource anything you can think of!

Media Partners


World Pharma News

Supporters
http://www.worldpharmanews.com/



pharmaphorum

Supporters
http://www.pharmaphorum.com

pharmaphorum drives innovation within the pharmaceutical industry, by bringing healthcare together through a suite of media services that help produce and disseminate thought leadership, combined with an online platform for communicating messages to a global audience.Visit www.pharmaphorum.com


Pharmaceutical Technology

Supporters
http://www.pharmaceutical-technology.com

Pharmaceutical-technology.com is the only website focusing specifically on issues relevant to pharmaceutical professionals working with technology, be it development, engineering, IT or production. Pharmaceutical-technology.com brings you the latest in industry projects and updates, along with the news, views and trends that leading professionals – from senior executives to manufacturing managers and heads of procurement – require to stay on top of their field.


MedTube

Supporters
https://medtube.net/



Contract Biotechnology

Supporters
http://www.contract-biotechnology.com

Contract-Biotechnology.com is a web-based platform for laboratory outsourcing solutions. It is an online R&D matching tool that connects Scientifics and service and product providers worldwide. The platform Contract-Biotechnology.com would help you in the process of finding the right partner saving time and money, because with one single and secure application you would be able to receive multiple quotes quickly, keeping your contact information confidential. Contract-Biotechnology.com is the new Collaboration Network Model for Discovery Research and Development. Contract-Biotechnology.com team has extensive experience working for pharmaceuticals, biotechs, universities and academic research institutes and can help you addressing your key gaps.


Pharmavision

Supporters
http://www.pharmavision.co.uk

PharmaVision offers a consultancy service providing independent pharmaceutical thematic research to the healthcare industry, the investment community and competitive intelligence specialists. We perform due diligence research and provide expert commentary in healthcare. Our reports combine scientific analysis in drug delivery, R&D technologies and pharmaceutical products including patient modelling, product/technology forecasts and market trends evaluation.


Biocompare

Supporters
http://www.biocompare.com

Biocompare.com is the leading resource for up-to-date product information, product reviews, and new technologies for life scientists. Biocompare combines an in-depth knowledge of life science products and new technologies with the power of the Internet to offer scientists the most dynamic, relevant, and innovative media-based marketplace for life science information.


American Pharmaceutical Review

Supporters
http://www.americanpharmaceuticalreview.com

Start receiving your free copy today. American Pharmaceutical Review is a review of the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:Separations and purification, Drug Delivery, Biopharmaceutical Processing, Biopharmaceutical Development, Formulation development, Manufacturing, Microbiology, Instrumentation, Spectroscopy


Rapid Microbiology.com

Supporters
https://www.rapidmicrobiology.com

rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide, find the right products for your microbiology lab using our specially designed search functions. To keep up-to-date with the latest microbiology news get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.


Drug Discovery Today

Supporters
http://www.drugdiscoverytoday.com/

Drug Discovery Today covers the whole of the preclinical drug discovery process. The reviews are cutting edge, written by experts in their respective fields and cover all aspects of drug discovery from genomic and proteomic approaches, computational drug design, medicinal chemistry and the translation of these sciences to therapies.


Pharmalicensing

Supporters
http://www.pharmalicensing.com

Pharmalicensing (www.pharmalicensing.com) is the premier biopharmaceutical Open Innovation resource designed for professionals involved with partnering, licensing and business development worldwide. Actively supporting all forms of partnering and in- and out-licensing activities, Pharmalicensing utilizes the unique online Showcase Profiling & Discover services, as well as its renowned Partnering Search service leveraging its global network of industry experts, to enable companies to identify and engage with appropriate partners around the world. Pharmalicensing is actively utilized by many tens of thousands of industry professionals each month. Pharmalicensing is a division of Cognis Group, Inc.

SAVE TO


Outlook Calendar  OUTLOOK CALENDAR
Google Calendar  GOOGLE CALENDAR
ICal Calendar  ICAL CALENDAR
Yahoo! Calendar  YAHOO! CALENDAR

Copthorne Tara Hotel

Scarsdale Place
Kensington
London W8 5SR
United Kingdom

Copthorne Tara Hotel

The Copthorne Tara Hotel London Kensington is an elegant contemporary four-star hotel in prestigious Kensington, located just a two minutes walk from High Street Kensington underground station, making exploring easy. The hotel offers well-appointed and comfortable guest rooms combining Standard, Superior and Club accommodation. Club rooms offer iconic views over the city and include Club Lounge access for complimentary breakfast and refreshments. Guests can sample the authentic Singaporean, Malaysian and Chinese cuisine at Bugis Street, traditional pub fare at the Brasserie Restaurant & Bar or relax with a delicious drink at West8 Cocktail Lounge & Bar.

The Copthorne Tara Hotel boasts 745 square meters of flexible meeting space, consisting of the Shannon Suite and the Liffey Suite, ideal for hosting conferences, weddings and social events. Facilities include access to the business centre 24 hours a day, fully equipped fitness room, gift shop, theatre desk and Bureau de Change. With ample onsite parking outside the London congestion charge zone and excellent transport links via Heathrow Airport, the hotel is the perfect location for business or leisure stays. The hotel is within close proximity to the shops of High Street Kensington, Knightsbridge and Westfield London, Olympia Conference Centre, Royal Albert Hall, Kensington Palace and Hyde Park.

 

HOTEL BOOKING FORM

Title

SubTitle
speaker image

Content


Title


Description

Download


WHAT IS CPD?

CPD stands for Continuing Professional Development’. It is essentially a philosophy, which maintains that in order to be effective, learning should be organised and structured. The most common definition is:

‘A commitment to structured skills and knowledge enhancement for Personal or Professional competence’

CPD is a common requirement of individual membership with professional bodies and Institutes. Increasingly, employers also expect their staff to undertake regular CPD activities.

Undertaken over a period of time, CPD ensures that educational qualifications do not become obsolete, and allows for best practice and professional standards to be upheld.

CPD can be undertaken through a variety of learning activities including instructor led training courses, seminars and conferences, e:learning modules or structured reading.

CPD AND PROFESSIONAL INSTITUTES

There are approximately 470 institutes in the UK across all industry sectors, with a collective membership of circa 4 million professionals, and they all expect their members to undertake CPD.

For some institutes undertaking CPD is mandatory e.g. accountancy and law, and linked to a licence to practice, for others it’s obligatory. By ensuring that their members undertake CPD, the professional bodies seek to ensure that professional standards, legislative awareness and ethical practices are maintained.

CPD Schemes often run over the period of a year and the institutes generally provide online tools for their members to record and reflect on their CPD activities.

TYPICAL CPD SCHEMES AND RECORDING OF CPD (CPD points and hours)

Professional bodies and Institutes CPD schemes are either structured as ‘Input’ or ‘Output’ based.

‘Input’ based schemes list a precise number of CPD hours that individuals must achieve within a given time period. These schemes can also use different ‘currencies’ such as points, merits, units or credits, where an individual must accumulate the number required. These currencies are usually based on time i.e. 1 CPD point = 1 hour of learning.

‘Output’ based schemes are learner centred. They require individuals to set learning goals that align to professional competencies, or personal development objectives. These schemes also list different ways to achieve the learning goals e.g. training courses, seminars or e:learning, which enables an individual to complete their CPD through their preferred mode of learning.

The majority of Input and Output based schemes actively encourage individuals to seek appropriate CPD activities independently.

As a formal provider of CPD certified activities, SMI Group can provide an indication of the learning benefit gained and the typical completion. However, it is ultimately the responsibility of the delegate to evaluate their learning, and record it correctly in line with their professional body’s or employers requirements.

GLOBAL CPD

Increasingly, international and emerging markets are ‘professionalising’ their workforces and looking to the UK to benchmark educational standards. The undertaking of CPD is now increasingly expected of any individual employed within today’s global marketplace.

CPD Certificates

We can provide a certificate for all our accredited events. To request a CPD certificate for a conference , workshop, master classes you have attended please email events@smi-online.co.uk

Event Title

Headline

Text
Read More

I would like to speak at an event

I would like to attend an event

I would like to sponsor/exhibit at an event

SIGN UP OR LOGIN

Sign up
Forgotten Password?

Contact SMi GROUP LTD

UK Office
Opening Hours: 9.00 - 17.30 (local time)
SMi Group Ltd, 1 Westminster Bridge Road, London, SE1 7XW, United Kingdom
Tel: +44 (0) 20 7827 6000 Fax: +44 (0) 20 7827 6001
Website: http://www.smi-online.co.uk Email: events@smi-online.co.uk
Registered in England No: 3779287 VAT No: GB 976 2951 71




Forgotten Password

Please enter the email address you registered with. We will email you a new password.

Thank you for visiting our event

If you would like to receive further information about our events, please fill out the information below.

By ticking above you are consenting to receive information by email from SMi.
Full details of our privacy policy can be found here https://www.smi-online.co.uk/privacy-legals/privacy-policy/.
Should you wish to update your contact preferences at any time you can contact us at data@smi-online.co.uk.
Should you wish to be removed from any future mailing lists please click on the following link http://www.smi-online.co.uk/opt-out